FLT3 inhibitors potentially improve response rates in acute myeloid leukemia harboring t(6;9)(DEK::NUP214): the Mayo Clinic experience. - Csizmar CM; Saliba AN; Greipp PT; Alkhateeb H; Begna KH; Foran JM; Gangat N; Hogan WJ; Hook CC; Litzow MR; Mangaonkar AA; Palmer JM; et al. (Haematologica, 2024)